Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hauser files Chapter 11

This article was originally published in The Tan Sheet

Executive Summary

El Segundo, Calif.-based supplement supplier files for bankruptcy with U.S. Bankruptcy Court for Central District of California April 1. Wholly-owned subsidiaries Botanicals International Extracts, ZetaPharm, Hauser Technical Services also file voluntary petitions, although Zuellig Botanicals, which does business as BI Nutraceuticals, "is not, and will not be a part of Hauser's bankruptcy filing," firm says. In September, Hauser sold Shuster Labs for $7.7 mil. to help pay down its debt (1"The Tan Sheet" Sept. 2, 2002, In Brief)...

You may also be interested in...

Hauser restructuring

Supplement supplier announces sale of Shuster Labs contract services division to Specialized Technology Resources for $7.7 mil. cash. Proceeds from the sale will help Hauser "pay down a substantial portion of its debt," firm says; Hauser was given until Aug. 31 to pay its Wells Fargo Bank loans (1"The Tan Sheet" July 8, 2002, p. 9)...

Triptan Switches Offer Hope For Australia’s OTC Market

Switch expert Natalie Gauld says recent triptan switch recommendations signal a turnaround for Australia's OTC market.

Bharat Biotech Plans Coronavirus Vaccine

After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts